glp-1 news 2025 october 21 Pharmacy Pricing Update (Dec 2025) Cardiovascular Effects and Tolerability of
Description
2, 24 Nov
47 Given the complementary and synergistic effects of GIP and GLP-1 receptor agonism, 48 the results of the SURPASS CVOT trial that will comprehensively assess tirzepatides cardiovascular safety and efficacy against the GLP-1 RA dulaglutide in patients with T2DM and established cardiovascular disease, are eagerly awaited
Boosting GLP-1 Medications Impact These grains do more than just provide nutrients they actively support the effectiveness of GLP-1 medications
In contrast, around 44% of people on Wegovy experienced nausea
Because the drug slows stomach emptying, it can raise aspiration risk during surgery or a scope, and many guidelines now advise pausing it beforehand (Jalleh 2026)
